Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendell C Valdecantos

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Dermatologic Clinics|July 6, 2013
Psoriasis as autoinflammatory diseaseJoaquin J Rivas Bejarano, Wendell C Valdecantos
Journal of Drugs in Dermatology : JDD|August 13, 2015
Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With PsoriasisRonald Prussick, Kristina Unnebrink, Wendell C Valdecantos
Journal of Drugs in Dermatology : JDD|May 12, 2016
Reduction in C-Reactive-Protein Levels With Adalimumab Therapy in Patients With Moderate-to-Severe Hand and/or Foot PsoriasisCraig L Leonardi, Kristina Unnebrink, Wendell C Valdecantos
Current Medical Research and Opinion|February 24, 2021
Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United StatesMaya L Hanna, David Singer, Wendell C Valdecantos
Dermatologic Clinics|July 6, 2013
Role of interleukin 1 in atopic dermatitisWilliam Abramovits, Joaquin J Rivas Bejarano, Wendell C Valdecantos
Journal of the American Academy of Dermatology|April 11, 2016
Systematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agentPaul S Yamauchi, Robert Bissonnette, Henrique D Teixeira, et al.
JAMA Dermatology|August 10, 2022
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health RecordsCarla L Zema, Wendell C Valdecantos, Jonathan Weiss, et al.
Current Medical Research and Opinion|July 22, 2021
Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United StatesMaya L Hanna, David Singer, Shaun D Bender, et al.
American Journal of Clinical Dermatology|January 31, 2018
Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or PsoriasisCaitriona Ryan, Jeffrey M Sobell, Craig L Leonardi, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Palmoplantar Pustulosis has a Greater Disease Burden than Plaque Psoriasis: Real-World Evidence From the CorEvitas Psoriasis RegistryMark G Lebwohl, Rose Anne Medeiros, Rachel H Mackey, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Dermatologic Clinics|July 6, 2013
Psoriasis as autoinflammatory diseaseJoaquin J Rivas Bejarano, Wendell C Valdecantos
Journal of Drugs in Dermatology : JDD|August 13, 2015
Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With PsoriasisRonald Prussick, Kristina Unnebrink, Wendell C Valdecantos
Journal of Drugs in Dermatology : JDD|May 12, 2016
Reduction in C-Reactive-Protein Levels With Adalimumab Therapy in Patients With Moderate-to-Severe Hand and/or Foot PsoriasisCraig L Leonardi, Kristina Unnebrink, Wendell C Valdecantos
Current Medical Research and Opinion|February 24, 2021
Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United StatesMaya L Hanna, David Singer, Wendell C Valdecantos
Dermatologic Clinics|July 6, 2013
Role of interleukin 1 in atopic dermatitisWilliam Abramovits, Joaquin J Rivas Bejarano, Wendell C Valdecantos
Journal of the American Academy of Dermatology|April 11, 2016
Systematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agentPaul S Yamauchi, Robert Bissonnette, Henrique D Teixeira, et al.
JAMA Dermatology|August 10, 2022
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health RecordsCarla L Zema, Wendell C Valdecantos, Jonathan Weiss, et al.
Current Medical Research and Opinion|July 22, 2021
Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United StatesMaya L Hanna, David Singer, Shaun D Bender, et al.
American Journal of Clinical Dermatology|January 31, 2018
Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or PsoriasisCaitriona Ryan, Jeffrey M Sobell, Craig L Leonardi, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Palmoplantar Pustulosis has a Greater Disease Burden than Plaque Psoriasis: Real-World Evidence From the CorEvitas Psoriasis RegistryMark G Lebwohl, Rose Anne Medeiros, Rachel H Mackey, et al.
Pageof 2